Aprotinin and preservation of myocardial function after ischemia-reperfusion injury (Q35074008)

6 August 2017

1 reference

title

Aprotinin and preservation of myocardial function after ischemia-reperfusion injury (English)

1 reference

6 August 2017

1 reference

David A Bull

1

1 reference

6 August 2017

Jennifer Maurer

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

The Annals of Thoracic Surgery

6 August 2017

published in

1 reference

6 August 2017

volume

75

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

S735-9

1 reference

Myocardial apoptosis and ischemic preconditioning

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin and the systemic inflammatory response after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Preventing the inflammatory response to open-heart surgery: the role of aprotinin and other protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin reduces nitric oxide production in vitro and in vivo in a dose-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin impairs endothelium-dependent relaxation in rat aorta and inhibits nitric oxide release from rat coronary endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

The effect of aprotinin on ischemia-reperfusion injury in the rabbit kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin preserves myocardial biochemical function during cold storage through suppression of tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Are macrophages involved in early myocardial reperfusion injury?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Leukocyte adhesion to the coronary microvasculature during ischemia and reperfusion in an in vivo canine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Murine hypodense eosinophils induce tumour cell apoptosis by a granzyme B-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Inhibition of cytotoxic T-lymphocyte-triggered apoptosis by target cell surface-coupled aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Leukocyte accumulation and hemodynamic changes in the cerebral microcirculation during early reperfusion after stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Ranitidine reduces ischemia/reperfusion-induced liver injury in rats by inhibiting neutrophil activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Leukocyte accumulation and changes in extra-renal organs during renal ischemia reperfusion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Decreased lung ischemia-reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Effect of cold-ischemia time on C-X-C chemokine expression and neutrophil accumulation in the graft liver after orthotopic liver transplantation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Hyperbaric oxygen and neutrophil accumulation/tissue damage during permanent focal cerebral ischaemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

High-dose aprotinin therapy: a review of the first five years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Cardioprotective effect of pump prime aprotinin in coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Leukocyte integrin expression in patients undergoing cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Does aprotinin modify the effects of ischaemia-reperfusion on the myocardial performance of a blood perfused isolated rabbit heart?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Action of aprotinin in myocardial ischemia - an investigation using a plasma-free model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Na(+)/H(+)-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Reduced inotropic support after aprotinin therapy during pediatric cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Aprotinin improves pulmonary function during reperfusion in an isolated lung model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

Addition of aprotinin to organ preservation solutions decreases lung reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2904702-1

10.1016/S0003-4975(02)04702-1

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference